Works about MYELOPROLIFERATIVE neoplasms

Results: 2672
    1

    Allogeneic hematopoietic cell transplantation with a combination of posttransplantation bendamustine and cyclophosphamide in refractory myeloid neoplasms.

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 10, p. 1, doi. 10.1002/cncr.35893
    By:
    • Moiseev, Ivan;
    • Bondarenko, Sergey;
    • Vlasova, Yulia;
    • Morozova, Elena;
    • Smirnova, Anna;
    • Epifanovskaya, Olga;
    • Zhogolev, Dmitrii;
    • Chernishova, Daria;
    • Meliboev, Azamjon;
    • Khudayberdiev, Jamshidbek;
    • Mazing, Alexandra;
    • Lapin, Sergey;
    • Kholopova, Irina;
    • Botina, Anna;
    • Baykov, Vadim;
    • Popova, Marina;
    • Kosarev, Oleg;
    • Kulagin, Alexander
    Publication type:
    Article
    2
    3
    4

    Chronic Myeloid Leukemia: A Review.

    Published in:
    JAMA: Journal of the American Medical Association, 2025, v. 333, n. 18, p. 1618, doi. 10.1001/jama.2025.0220
    By:
    • Jabbour, Elias;
    • Kantarjian, Hagop
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Hematology and hemostasis.

    Published in:
    Clinical Chemistry & Laboratory Medicine, 2025, v. 63, n. 1, p. s1362, doi. 10.1515/cclm-2025-8051
    Publication type:
    Article
    16
    17
    18
    19
    20

    Oncogenic Kras Initiates Leukemia in Hematopoietic Stem Cells.

    Published in:
    PLoS Biology, 2009, v. 7, n. 3, p. e1000059, doi. 10.1371/journal.pbio.1000059
    By:
    • Sabnis, Amit J.;
    • Cheung, Laurene S.;
    • Dail, Monique;
    • Kang, Hio Chung;
    • Santaguida, Marianne;
    • Hermiston, Michelle L.;
    • Passegué, Emmanuelle;
    • Shannon, Kevin;
    • Braun, Benjamin S.
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27

    Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis.

    Published in:
    NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00144-9
    By:
    • Parenti, Sandra;
    • Rontauroli, Sebastiano;
    • Carretta, Chiara;
    • Mallia, Selene;
    • Genovese, Elena;
    • Chiereghin, Chiara;
    • Peano, Clelia;
    • Tavernari, Lara;
    • Bianchi, Elisa;
    • Fantini, Sebastian;
    • Sartini, Stefano;
    • Romano, Oriana;
    • Bicciato, Silvio;
    • Tagliafico, Enrico;
    • Della Porta, Matteo;
    • Manfredini, Rossella
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Association of TP53 P72R and MDM2 SNP309 variants with susceptibility to chronic myeloid leukaemia development in Algerian population: TP53 P72R C allele is a strong risk marker and MDM2 SNP309 G allele has a protective effect.

    Published in:
    South Asian Journal of Experimental Biology, 2022, v. 12, n. 1, p. 28, doi. 10.38150/sajeb.12(1).p28-34
    By:
    • Benseddik, Khedidja;
    • Abderrahmane, Rym;
    • Boudjemaa, Abdellah;
    • Meriem, Aberkane;
    • Samia, Dorgham;
    • Zohra, Touala Chaîla;
    • Naima, Meroufel Djabaria
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50